Sign In
Buy AZN
$176.43
+1.50 (+0.86%)
At Close: Jun 22, 2026
Cancer Stocks That Are Advancing the Future of Oncology Care
01:01pm, Monday, 18'th May 2026
Oncology innovation is accelerating as AI, immunotherapy and targeted drugs drive growth for cancer-focused biotech and pharma stocks.
AstraZeneca Wins FDA Approval for $5 Billion Blood Pressure Drug
08:02am, Monday, 18'th May 2026
AstraZeneca (AZN) has won US FDA approval for Baxfendy, giving the drugmaker a potentially important new growth lever as it aims to generate more than $5 billio
7 Healthcare AI Stocks Under $50 With Huge Upside Potential
07:35am, Monday, 18'th May 2026
Healthcare AI stocks have been hammered in 2026, with several names down 30% to 65% year to date even as their underlying platforms keep maturing.
BAXFENDY approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension
07:00am, Monday, 18'th May 2026
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca's BAXFENDY™ (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in comb
AstraZeneca wins US approval for first-in-class blood pressure drug and expands cancer treatment Enhertu
03:53am, Monday, 18'th May 2026
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has secured US approval for Baxfendy, the first in a new class of blood pressure medication to reach the market in...
Sintana Energy raises $11.5m to support exploration plans in Namibia
03:46am, Monday, 18'th May 2026
Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF, FRA:3ZX1, AIM:SEI) has conditionally raised US$11.5 million to back a busy exploration programme, including...
88 Energy upgrades estimates for South Prudhoe project
03:31am, Monday, 18'th May 2026
88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ) told investors that it has lifted the scale of its South Prudhoe project in Alaska, upgrading total...
AstraZeneca wins US approval for first-in-class blood pressure drug and expands cancer treatment Enhertu
02:55am, Monday, 18'th May 2026
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has secured US approval for Baxfendy, the first in a new class of blood pressure medication to reach the market in more than two decades. The drug works by blocki
AstraZeneca Gets U.S. Approval for Hypertension Drug
02:13am, Monday, 18'th May 2026
The pharmaceutical company expects the drug Baxfendy to generate multibillion-dollar annual sales at its peak.
AstraZeneca's blood pressure drug wins U.S. approval
02:01am, Monday, 18'th May 2026
Anglo-Swedish drugmaker AstraZeneca said on Monday its hypertension pill baxdrostat had been approved in the United States, offering a new treatment option for millions of patients with uncontrolled h
Which Pharma Giant Offers Better Growth: AstraZeneca or AbbVie?
01:41pm, Friday, 15'th May 2026
AZN and ABBV both boast strong drug pipelines and growth outlooks, but differences in valuation, dividends and LOE risks set them apart.
AstraZeneca's Imfinzi with pre-surgery drug boosts survival in bladder cancer trial
02:59am, Thursday, 14'th May 2026
AstraZeneca said on Thursday that a late-stage trial of Imfinzi, combined with a targeted therapy prior to a surgery, showed significantly improved survival rate in patients with muscle-invasive
Owkin to Build AI Agents as Part of a Multi-Year K Pro License Agreement With AstraZeneca
01:00am, Wednesday, 13'th May 2026
NEW YORK & PARIS--(BUSINESS WIRE)--Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to revolutionize drug discovery and development, today announced an agreement with A
LUND, SE / ACCESS Newswire / May 12, 2026 / BioInvent International (STO:BINV) - BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a leader in the discovery of novel immune-modulatory
Polen International Growth Q1 2026 Portfolio Activity
02:23pm, Sunday, 10'th May 2026
In Q1 2026, Polen International Growth Portfolio returned -14.4% (net of fees) compared to -0.7% for the Index. We initiated new positions in TSMC, Rheinmetall, Saab, Mitsubishi Heavy Industries, Astr
